$842.37
0.46% day before yesterday
NYSE, Nov 14, 10:00 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$842.09
+60.19 7.70% 1M
+159.81 23.42% 6M
+272.18 47.76% YTD
+231.93 38.01% 1Y
+481.01 133.21% 3Y
+658.43 358.50% 5Y
+659.74 361.80% 10Y
+795.50 1,707.45% 20Y
NYSE, Closing price Fri, Nov 14 2025
-4.15 0.49%

New AI Insights on McKesson Insights AI Insights on McKesson

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$103.9b
Enterprise Value
$107.7b
Net debt
$3.8b
Cash
$4.0b
Shares outstanding
124.0m
Valuation (TTM | estimate)
P/E
26.0 | 21.8
P/S
0.3 | 0.3
EV/Sales
0.3 | 0.3
EV/FCF
17.9
P/B
negative
Dividends
DPS
$2.75
Yield 1Y | 5Y
0.3% | 0.6%
Growth 1Y | 5Y
14.6% | 11.2%
Payout 1Y | 3Y
10.7% | 9.9%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$387.1b | $412.9b
EBITDA
$5.8b | $6.7b
EBIT
$5.2b | $6.2b
Net Income
$4.0b | $4.8b
Free Cash Flow
$6.0b
Growth (TTM | estimate)
Revenue
17.2% | 15.0%
EBITDA
16.0% | 32.3%
EBIT
18.5% | 40.4%
Net Income
59.0% | 45.7%
Free Cash Flow
40.1%
Margin (TTM | estimate)
Gross
3.5%
EBITDA
1.5% | 1.6%
EBIT
1.3%
Net
1.0% | 1.2%
Free Cash Flow
1.6%
Financial Health
Equity Ratio
-2.8%
Return on Equity
-158.9%
ROCE
32.2%
ROIC
-
Debt/Equity
-4.5
More
EPS
$32.4
FCF per Share
$48.6
Short interest
1.7%
Employees
48k
Rev per Employee
$7.5m
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a McKesson forecast:

18x Buy
82%
4x Hold
18%

Analyst Opinions

22 Analysts have issued a McKesson forecast:

Buy
82%
Hold
18%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
387,094 387,094
17% 17%
100%
- Direct Costs 373,654 373,654
18% 18%
97%
13,440 13,440
4% 4%
3%
- Selling and Administrative Expenses 8,250 8,250
4% 4%
2%
- Research and Development Expense - -
-
-
5,839 5,839
16% 16%
2%
- Depreciation and Amortization 649 649
0% 0%
0%
EBIT (Operating Income) EBIT 5,190 5,190
18% 18%
1%
Net Profit 4,033 4,033
59% 59%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Positive
Seeking Alpha
one day ago
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth...
Neutral
Seeking Alpha
6 days ago
McKesson Corporation ( MCK ) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM EST Company Participants Britt Vitalone - Executive VP & CFO Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thank you for coming to the UBS Healthcare Conference.
Neutral
Seeking Alpha
11 days ago
McKesson Corporation ( MCK ) Q2 2026 Earnings Call November 5, 2025 4:30 PM EST Company Participants Jeni Dominguez - Head of Investor Relations Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Brian Tanquilut - Jefferies LLC, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities...
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 48,000
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today